Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > LABS is involved with McMaster in the field of
View:
Post by subaru1i on Mar 19, 2024 10:39am

LABS is involved with McMaster in the field of

antimicrobial resistance and development of new classes of antibiotics, recall cannabinoids tackling very diificult MRSA.   We'll be getting our reward very shortly as well.

Gerry Wright, a professor at Hamilton’s McMaster University, was one of five scholars announced Tuesday to each receive the cash award for outstanding contributions in their respective fields of health sciences, engineering, humanities, natural sciences and social sciences.

Wright was recognized for his expertise in bacteria and viruses evolving in ways that make antibiotics less effective in treating infections, and for co-founding an advanced course on antibiotic resistance at a facility in France for researchers, clinicians and policymakers from around the world.

Antimicrobial resistance is increasingly becoming a major threat to public health, he said in an interview, recounting his own experience with a salmonella infection a decade ago on a trip to Europe, where he was prescribed an antibiotic that did not work.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities